Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
saunders jh
(255 results)?
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2.
Lancet Glob Health. 2023.
PMID: 37858585
Free article.
Clinical Trial.
Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.
Wassenaar M, Fombah AE, Chen H, Owusu-Kyei K, Williams J, Sunders JC, Llach M, Quinto L, Sesay T, Samai M, Menéndez C, González R.
Wassenaar M, et al.
BMC Public Health. 2024 Jan 10;24(1):143. doi: 10.1186/s12889-023-17534-2.
BMC Public Health. 2024.
PMID: 38200476
Free PMC article.
Item in Clipboard
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
Ishola D, Manno D, Afolabi MO, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Leyssen M, Greenwood B, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group.
Ishola D, et al.
Lancet Infect Dis. 2022 Jan;22(1):97-109. doi: 10.1016/S1473-3099(21)00125-0. Epub 2021 Sep 13.
Lancet Infect Dis. 2022.
PMID: 34529963
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Afolabi MO, Ishola D, Manno D, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Greenwood B, Leyssen M, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group.
Afolabi MO, et al.
Lancet Infect Dis. 2022 Jan;22(1):110-122. doi: 10.1016/S1473-3099(21)00128-6. Epub 2021 Sep 13.
Lancet Infect Dis. 2022.
PMID: 34529962
Free PMC article.
Clinical Trial.
Item in Clipboard
Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone.
Fombah AE, Chen H, Owusu-Kyei K, Quinto L, Gonzalez R, Williams J, Berne ML, Wassenaar M, Jalloh A, Sunders JC, Ramirez M, Bertran-Cobo C, Saute F, Ekouevi DK, Briand V, Kamara ARY, Sesay T, Samai M, Menendez C.
Fombah AE, et al.
Malar J. 2023 May 2;22(1):145. doi: 10.1186/s12936-023-04575-6.
Malar J. 2023.
PMID: 37127633
Free PMC article.
Item in Clipboard
Cite
Cite